Literature DB >> 29847765

Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.

John F Seymour1, Mehrdad Mobasher2, Arnon P Kater3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29847765     DOI： 10.1056/NEJMc1805135

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Targeting CD20 takes the backseat in CLL.

Authors:  John C Byrd
Journal:  Blood       Date:  2019-03-07       Impact factor: 22.113

2.  Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.

Authors:  Jacob D Soumerai; Ai Ni; Mohamed Darif; Anil Londhe; Guan Xing; Yong Mun; Neil E Kay; Tait D Shanafelt; Kari G Rabe; John C Byrd; Asher A Chanan-Khan; Richard R Furman; Peter Hillmen; Jeffrey Jones; John F Seymour; Jeffrey P Sharman; Lucille Ferrante; Mehrdad Mobasher; Thomas Stark; Vijay Reddy; Lyndah K Dreiling; Pankaj Bhargava; Angela Howes; Danelle F James; Andrew D Zelenetz
Journal:  Lancet Haematol       Date:  2019-05-17       Impact factor: 18.959

3.  Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.

Authors:  Esteban Enrique Elias; Valeria Judith Sarapura Martinez; Mikele Amondarain; Ana Colado; Gregorio Cordini; Raimundo Fernando Bezares; Horacio Fernandez Grecco; Maria Del Rosario Custidiano; Julio César Sánchez Ávalos; Gonzalo Garate; Miguel A Pavlovsky; Mercedes Borge; Mirta Giordano; Romina Gamberale
Journal:  Cancer Immunol Immunother       Date:  2021-08-31       Impact factor: 6.968

4.  CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration.

Authors:  Kirsti L Walker; Sean P Rinella; Nicholas J Hess; David P Turicek; Sabrina A Kabakov; Fen Zhu; Myriam N Bouchlaka; Sydney L Olson; Monica M Cho; Aicha E Quamine; Arika S Feils; Tara B Gavcovich; Lixin Rui; Christian M Capitini
Journal:  Leuk Lymphoma       Date:  2021-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.